156 related articles for article (PubMed ID: 34846783)
1. Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis.
Valeriani E; Di Nisio M; Porceddu E; Agostini F; Pola R; Spoto S; Donadini MP; Ageno W; Porfidia A
J Thromb Haemost; 2022 Mar; 20(3):661-670. PubMed ID: 34846783
[TBL] [Abstract][Full Text] [Related]
2. Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.
Bleker SM; van Es N; Kleinjan A; Büller HR; Kamphuisen PW; Aggarwal A; Beyer-Westendorf J; Camporese G; Cosmi B; Gary T; Ghirarduzzi A; Kaasjager K; Lerede T; Marschang P; Meijer K; Otten HM; Porreca E; Righini M; Verhamme P; van Wissen S; Di Nisio M
J Thromb Haemost; 2016 May; 14(5):973-81. PubMed ID: 26866515
[TBL] [Abstract][Full Text] [Related]
3. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis.
Wang TF; Kou R; Carrier M; Delluc A
J Thromb Haemost; 2024 Mar; 22(3):749-764. PubMed ID: 38065528
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of the incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis.
Espitia O; Raimbeau A; Planquette B; Katsahian S; Sanchez O; Espinasse B; Bénichou A; Murris J
J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101688. PubMed ID: 37717788
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review.
Bleker SM; van Es N; van Gils L; Daams JG; Kleinjan A; Büller HR; Di Nisio M
Thromb Res; 2016 Apr; 140 Suppl 1():S81-8. PubMed ID: 27067985
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center.
ALKindi SY; Chai-Adisaksopha C; Cheah M; Linkins LA
Thromb Res; 2018 Jun; 166():92-95. PubMed ID: 29704767
[TBL] [Abstract][Full Text] [Related]
7. Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
Vedovati MC; Tratar G; Mavri A; Mazzetti M; Salazar Rosa V; Pierpaoli L; Cotugno M; Agnelli G; Becattini C
Int J Cardiol; 2021 Sep; 339():158-163. PubMed ID: 34245794
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature.
Schastlivtsev I; Lobastov K; Tsaplin S; Kanzafarova I; Barinov V; Laberko L; Rodoman G; Zhuravlev S
Thromb Res; 2019 Sep; 181():24-28. PubMed ID: 31326717
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
11. Risk for recurrence of symptomatic upper-extremity deep vein thrombosis in patients without cancer: Analysis of three RIETE cohorts.
Núñez Fernández MJ; Padín Paz EM; Vázquez Temprano N; Nieto Rodríguez JA; Marchena Yglesias PJ; Imbalzano E; Montenegro AC; Fernández Jiménez B; Rivera A; Espitia O; Monreal M
Vasc Med; 2023 Aug; 28(4):324-330. PubMed ID: 37272085
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).
Davies GA; Lazo-Langner A; Gandara E; Rodger M; Tagalakis V; Louzada M; Corpuz R; Kovacs MJ
Thromb Res; 2018 Feb; 162():88-92. PubMed ID: 28416213
[TBL] [Abstract][Full Text] [Related]
13. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton DH; Monreal Bosch M; Amendola M; Wolfe L; Perez Ductor C; Lecumberri R; Levy MM;
J Vasc Surg Venous Lymphat Disord; 2017 Jan; 5(1):18-24.e1. PubMed ID: 27987605
[TBL] [Abstract][Full Text] [Related]
14. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
Pritchard ER; Murillo JR; Putney D; Hobaugh EC
J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic upper extremity deep vein thrombosis: A systematic review.
Yuen HLA; Tan E; Tran H; Chunilal SD
Eur J Haematol; 2022 Nov; 109(5):542-558. PubMed ID: 36053912
[TBL] [Abstract][Full Text] [Related]
16. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
[TBL] [Abstract][Full Text] [Related]
17. Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.
Isma N; Svensson PJ; Gottsäter A; Lindblad B
Thromb Res; 2010 Jun; 125(6):e335-8. PubMed ID: 20406709
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for people with cancer and central venous catheters.
Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study.
Xu J; Wang G; Chen X; Shen Y; Wang X; Wang H
Thromb J; 2023 Feb; 21(1):15. PubMed ID: 36726149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
